BHST
BioHarvest Sciences Inc. (BHST) is rated C (2.4/5) on Deltasharpe Prism, scored against Consumer Defensive sector peers. Its strongest pillar is Growth (B); its weakest is Momentum (D-). The rating has held at C for 6 weeks.
Quantitative Factor Evaluation • Updated
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-11-17 | B- (3.0) | B (3.4) | C- (1.9) | D- (0.9) | C+ (2.6) | C (2.4) |
| 2026-11-10 | B- (3.0) | B (3.4) | C- (1.9) | D (1.4) | C+ (2.6) | C (2.5) |
| 2026-11-03 | B- (3.0) | B (3.4) | C- (2.0) | D- (1.0) | C+ (2.6) | C (2.4) |
| 2026-10-27 | B- (3.0) | B (3.5) | C- (1.9) | D (1.3) | C (2.4) | C (2.4) |
| 2026-10-20 | B- (3.0) | B (3.5) | C- (1.9) | D- (1.1) | C (2.3) | C (2.4) |